Abstract: Slide Presentations |


Marwan K. Elya, MD; Ross G. Michel, MD*; Tarek A. Dernaika, MD; Gary T. Kinasewitz, MD; Jean I. Keddissi, MD
Author and Funding Information

University of Oklahoma Health Sciences Center, Oklahoma City, OK


Chest. 2008;134(4_MeetingAbstracts):s50003. doi:10.1378/chest.134.4_MeetingAbstracts.s50003
Text Size: A A A
Published online


PURPOSE:Improvement in spirometry after bronchodilator administration (BD) is characteristic of obstructive airway diseases, such as asthma. However, one occasionally encounters a restrictive pattern on testing that improves after BD. The aim of this study was to determine the total lung capacity (TLC) of patients with this reversible restrictive defect.

METHODS:Patients with restrictive spirometry who had a bronchodilator study were identified by review of all PFTs done at the Oklahoma City VAMC between January 2004 and August 2006. Restriction was defined as a decreased FVC (based on the values predicted for age, height and gender), with a normal FEV1/FVC. Responsiveness to BD was defined as an improvement in FEV1 and/or FVC of at least 12% and 200 ml. Clinical records of these patients were reviewed and those with follow up TLC measurements were analyzed.

RESULTS:A total of 2344 PFTs were reviewed, with 1593 undergoing BD including 84 patients (4%) who had a restrictive pattern and BD evaluation. Thirty three of 84 (39%) patients had a response to bronchodilator, with a moderately decreased prebronchodilator FVC (2.85+0.7 L, 65+11% of the predicted) including 8 (24%) with subsequent plethysmographic lung volume measurements. There was no difference between patients who underwent plethysmography, and those who did not, in terms of their clinical presentation, demographics, or baseline spirometry. In the former group, the mean TLC and RV averaged 92+12% and 122+32% of the predicted, respectively. The TLC was less than the lower limit of normal in only 2 patients. The DLCO averaged 65+15% of the predicted.

CONCLUSION:Reversible restrictive pattern appears to be a variant of obstructive lung disease in which complete closure of terminal lung units by contraction of alveolar ducts leads to low FVC despite a normal TLC.

CLINICAL IMPLICATIONS:In symptomatic patients, a therapeutic trial of BD may be of potential benefit.

DISCLOSURE:Ross Michel, No Financial Disclosure Information; No Product/Research Disclosure Information

Tuesday, October 28, 2008

2:30 PM - 4:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543